{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:15:39Z","timestamp":1793643339277,"version":"4.5.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.cmi.2019.04.031","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T03:16:59Z","timestamp":1557976619000},"page":"1501-1509","source":"Crossref","is-referenced-by-count":74,"title":["Intensive care management of influenza-associated pulmonary aspergillosis"],"prefix":"10.1016","volume":"25","author":[{"given":"P.","family":"Koehler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kochanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Shimabukuro-Vornhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.04.031_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMp1300375","article-title":"Epidemic influenza\u2014responding to the expected but unpredictable","volume":"368","author":"Bresee","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2019.04.031_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2807\/esm.07.11.00373-en","article-title":"Mild to moderate influenza activity in Europe and the detection of novel A(H1N2) and B viruses during the winter of 2001\u201302","volume":"7","author":"Paget","year":"2002","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2019.04.031_bib3","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1086\/344738","article-title":"Intercontinental circulation of human influenza A(H1N2) reassortant viruses during the 2001\u20132002 influenza season","volume":"186","author":"Xu","year":"2002","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.031_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030401","article-title":"Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States","volume":"3","author":"Brownstein","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.cmi.2019.04.031_bib5","unstructured":"World Health Organization - International travel and health. Available at: https:\/\/www.who.int\/ith\/diseases\/influenza_seasonal\/en\/; last accessed 16 April 2019."},{"key":"10.1016\/j.cmi.2019.04.031_bib6","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2019.04.031_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2019.02.011","article-title":"European all-cause excess and influenza-attributable mortality in the 2017\/18 season: should the burden of influenza B be reconsidered?","author":"Nielsen","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.031_bib8","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201612-2540LE","article-title":"Influenza-associated aspergillosis in critically ill patients","author":"van de Veerdonk","year":"2017","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.cmi.2019.04.031_bib9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/QCO.0000000000000504","article-title":"Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment","volume":"31","author":"Vanderbeke","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.031_bib10","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Resp Med"},{"key":"10.1016\/j.cmi.2019.04.031_bib11","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00134-017-4731-2","article-title":"Intensive care medicine research agenda on invasive fungal infection in critically ill patients","volume":"43","author":"Bassetti","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2019.04.031_bib12","first-page":"1742","article-title":"Mortality trends of acute respiratory distress syndrome in the United States from 1999 to 2013","volume":"13","author":"Cochi","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.cmi.2019.04.031_bib13","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1183\/13993003.01282-2015","article-title":"Influenza virus damages the alveolar barrier by disrupting epithelial cell tight junctions","volume":"47","author":"Short","year":"2016","journal-title":"Eur Resp J"},{"key":"10.1016\/j.cmi.2019.04.031_bib14","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1183\/09031936.00186214","article-title":"Influenza virus-induced lung injury: pathogenesis and implications for treatment","volume":"45","author":"Herold","year":"2015","journal-title":"Eur Resp J"},{"key":"10.1016\/j.cmi.2019.04.031_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1473-3099(13)70286-X","article-title":"Pathogenesis of influenza-induced acute respiratory distress syndrome","volume":"14","author":"Short","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.031_bib16","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1017\/S0950268811002603","article-title":"Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients","volume":"140","author":"Vehreschild","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.cmi.2019.04.031_bib17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination","volume":"149","author":"Bernard","year":"1994","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.cmi.2019.04.031_bib18","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin Definition The Berlin definition of ARDS","volume":"307","author":"Force* TADT","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2019.04.031_bib19","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201703-0548ST","article-title":"An official American thoracic society\/european society of intensive care medicine\/society of critical care medicine clinical practice guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome","volume":"195","author":"Fan","year":"2017","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.cmi.2019.04.031_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003844.pub4","article-title":"Lung protective ventilation strategy for the acute respiratory distress syndrome","author":"Petrucci","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2019.04.031_bib21","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cmi.2019.04.031_bib22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2019.04.031_bib23","series-title":"Textbook of critical care","author":"Vincent","year":"2017"},{"key":"10.1016\/j.cmi.2019.04.031_bib24","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1172\/JCI60331","article-title":"The acute respiratory distress syndrome","volume":"122","author":"Matthay","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cmi.2019.04.031_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.chom.2010.01.010","article-title":"Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection","volume":"7","author":"Jamieson","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cmi.2019.04.031_bib26","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.031_bib27","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciy866","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.031_bib28","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1100\/2011\/865239","article-title":"Tracheobronchial manifestations of Aspergillus infections","volume":"11","author":"Krenke","year":"2011","journal-title":"TheScientificWorldJournal"},{"key":"10.1016\/j.cmi.2019.04.031_bib29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey","volume":"43","author":"Cornillet","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.031_bib30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1086\/510535","article-title":"Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in\u00a0vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy","volume":"195","author":"Hope","year":"2007","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.031_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.idc.2015.10.003","article-title":"Contemporary strategies in the prevention and management of fungal infections","volume":"30","author":"Koehler","year":"2016","journal-title":"Infect Dis Clin N Am"},{"key":"10.1016\/j.cmi.2019.04.031_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myy091","article-title":"Breakthrough invasive fungal diseases in acute myeloid leukemia patients receiving mould active triazole primary prophylaxis after intensive chemotherapy: an Italian consensus agreement on definitions and management","volume":"57","author":"Girmenia","year":"2019","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2019.04.031_bib33","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","article-title":"Multicenter clinical evaluation of the (1-3) \u03b2-d-glucan assay as an aid to diagnosis of fungal infections in humans","volume":"41","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.031_bib34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/myc.12881","article-title":"Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test in bronchoalveolar lavage","volume":"62","author":"Jenks","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.031_bib35","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1007\/s00134-004-2448-5","article-title":"Post mortem examination in the intensive care unit: still useful?","volume":"30","author":"Dimopoulos","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2019.04.031_bib36","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"Meersseman","year":"2004","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.cmi.2019.04.031_bib37","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.031_bib38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A\u00a0clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.cmi.2019.04.031_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/myc.12869","article-title":"Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project","volume":"62","author":"Bassetti","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.031_bib40","first-page":"249","article-title":"Bronchoalveolar lavage Aspergillus galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test for diagnosis of invasive pulmonary Aspergillosis in patients with hematological malignancies","volume":"78","author":"Jenks","year":"2019","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2019.04.031_bib41","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00134-014-3608-x","article-title":"The ten diseases that look like ARDS","volume":"41","author":"Guerin","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2019.04.031_bib42","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.031_bib43","article-title":"Clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza","author":"Uyeki","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.031_bib44","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S2213-2600(14)70041-4","article-title":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data","volume":"2","author":"Muthuri","year":"2014","journal-title":"Lancet Resp Med"},{"key":"10.1016\/j.cmi.2019.04.031_bib45","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1182\/blood-2009-11-255455","article-title":"How I treat influenza in patients with hematologic malignancies","volume":"115","author":"Casper","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2019.04.031_bib46","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jmii.2017.06.001","article-title":"Clinical outcomes and prognostic factors of patients with severe influenza receiving intravenous peramivir salvage therapy in intensive care units","volume":"51","author":"Yeh","year":"2018","journal-title":"J\u00a0Microbiol Immunol Infect Wei Mian Yu gan Ran Za Zhi"},{"key":"10.1016\/j.cmi.2019.04.031_bib47","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/jmv.24232","article-title":"Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza","volume":"87","author":"Yoo","year":"2015","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.cmi.2019.04.031_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz101","article-title":"Effect of early oseltamivir treatment on mortality in critically ill patients with different types of influenza: a multi-season cohort study","author":"Lytras","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.031_bib49","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1164\/rccm.201101-0135OC","article-title":"Early corticosteroids in severe influenza A\/H1N1 pneumonia and acute respiratory distress syndrome","volume":"183","author":"Brun-Buisson","year":"2011","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.cmi.2019.04.031_bib50","doi-asserted-by":"crossref","first-page":"i39","DOI":"10.1093\/jac\/dkx032","article-title":"Invasive mould infections in the ICU setting: complexities and solutions","volume":"72","author":"Bassetti","year":"2017","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.04.031_bib51","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jfma.2017.06.002","article-title":"Higher mortality of severe influenza patients with probable aspergillosis than those with\u00a0and without other coinfections","volume":"116","author":"Ku","year":"2017","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.cmi.2019.04.031_bib52","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.diagmicrobio.2018.01.014","article-title":"Invasive pulmonary aspergillosis and influenza co-infection in immunocompetent hosts: case reports and review of the literature","volume":"91","author":"Shah","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.031_bib53","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2019.04.031_bib54","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2215\/CJN.08300813","article-title":"Acute respiratory distress syndrome and risk of AKI among critically ill patients","volume":"9","author":"Darmon","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cmi.2019.04.031_bib55","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/myc.12731","article-title":"Isavuconazole shortens the QTc interval","volume":"61","author":"Mellinghoff","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.031_bib56","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.031_bib57","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1128\/AAC.01919-15","article-title":"In\u00a0vitro activity of isavuconazole and comparators against clinical isolates of the Mucorales Order","volume":"59","author":"Arendrup","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.04.031_bib58","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00073-19","article-title":"EUCAST susceptibility testing of isavuconazole: MIC data for contemporary clinical mould and yeast isolates","author":"Jorgensen","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.04.031_bib59","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmi.2018.11.027","article-title":"Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management","volume":"25","author":"Lestrade","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.031_bib60","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/myc.12770","article-title":"Post-influenzal triazole-resistant aspergillosis following allogeneic stem cell transplantation","volume":"61","author":"Talento","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2019.04.031_bib61","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1007\/s00134-018-5332-4","article-title":"Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study","volume":"44","author":"Moreno","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2019.04.031_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz075","article-title":"Effects of influenza vaccination in the United States during the 2017\u20132018 influenza season","author":"Rolfes","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.031_bib63","unstructured":"Centers for Disease Control and Prevention (CDC). Available at: https:\/\/www.cdc.gov\/flu\/about\/disease\/high_risk.htm. Last accessed 18 April 2019."},{"key":"10.1016\/j.cmi.2019.04.031_bib64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00277-017-3196-2","article-title":"Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)","volume":"97","author":"Mellinghoff","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cmi.2019.04.031_bib65","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMct1103720","article-title":"Extracorporeal membrane oxygenation for ARDS in adults","volume":"365","author":"Brodie","year":"2011","journal-title":"N\u00a0Engl J Med"}],"updated-by":[{"DOI":"10.1016\/j.cmi.2019.12.022","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000}}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19302095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19302095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T02:44:49Z","timestamp":1606790689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X19302095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":65,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1198743X19302095"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.04.031","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}